Dimensional Fund Advisors
VTAE

Dimensional Fund Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Dimensional Fund Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-59,967
Closed -$1.25M – 3340
2016
Q3 		$1.25M Sell
59,967
-8,049
-12% -$92.7K ﹤0.01% 2886
2016
Q2 		$734K Sell
68,016
-39,735
-37% -$340K ﹤0.01% 2981
2016
Q1 		$714K Buy
107,751
+34,144
+46% +$311K ﹤0.01% 2987
2015
Q4 		$1.33M Buy
+73,607
New +$1.01M ﹤0.01% 2900

Dimensional Fund Advisors's VTAE Position: Q4 2016 in Review

Dimensional Fund Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 59,967 shares — an estimated $1.25M sold.

Dimensional Fund Advisors first reported a position in VTAE in Q4 2015 and held it in 4 quarters. The position peaked at $1.33M in Q4 2015. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Dimensional Fund Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Dimensional Fund Advisors sold 59,967 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.25M.
  • Dimensional Fund Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2015 and held it in 4 quarters.
  • Dimensional Fund Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.33M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Dimensional Fund Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.